Oxford University Press (OUP), The Journal of Infectious Diseases, 12(209), p. 1941-1948
Full text: Download
Background. Prospective evaluation of the antifungal drug, voriconazole, is needed to determine whether drug toxicity correlates with CYP2C19 genotype or serum concentrations of voriconazole or its metabolites.